Macronix International Co Ltd (TPE:2337)
NT$ 121.5 -7.5 (-5.81%) Market Cap: 240.49 Bil Enterprise Value: 247.44 Bil PE Ratio: 0 PB Ratio: 4.76 GF Score: 54/100

Q2 2025 Macronix International Co Ltd Earnings Call (Chinese, English) Transcript

Jul 30, 2025 / 08:00AM GMT
Release Date Price: NT$19.6 (+0.51%)

Key Points

Positve
  • Macronix International Co Ltd (TPE:2337) reported a strong performance in the second quarter of 2025.
  • The company provided positive guidance for the second half of the year, indicating confidence in future growth.
  • Macronix International Co Ltd (TPE:2337) has maintained a stable financial position, as highlighted by their Vice President.
  • The company is focusing on strategic initiatives to enhance operational efficiency.
  • Macronix International Co Ltd (TPE:2337) is committed to innovation and technological advancements, which are expected to drive future success.
Negative
  • The earnings call highlighted significant risks and uncertainties that could impact future results.
  • There is a potential for material differences between forward-looking statements and actual outcomes.
  • Macronix International Co Ltd (TPE:2337) faces challenges in maintaining its competitive edge in a rapidly evolving market.
  • The company may encounter difficulties in executing its strategic initiatives effectively.
  • Economic and geopolitical factors could pose risks to the company's operations and financial performance.
Operator;Chih;Yuan Lu
Macronix International Co Ltd - General Manager

Good afternoon, everyone, and welcome to Macronix's, the second quarter 2025 earnings call.

This is Macronix director of IR and new host for today. The format for today's event will be followed. First, Macronix President will summarize our operations in this quarter and followed by our guidance for the second half this year.

Afterward, Macronix's Vice President Paul Yeh will summarize our financial results. After that, Dr. Lu will provide us the business update and key messages.

And then we will open the line for the Q&A section.

As usual, I would like to remind everybody today's discussion may contain the forward-looking statements that are subject to the significant risk and uncertainty that could cost the actual result to differ materially from those in the statement.

Please refer to the safe in our press release.

And now I would like to turn to the call over to our President, Dr. Lu. And summarize the operation and current guidance.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot